KLRK1 Anticorps
(Killer Cell Lectin-Like Receptor Subfamily K, Member 1 (KLRK1))
Choisissez l’un des 126 anticorps KLRK1 de notre liste de produits basés sur 38 publications et 59 images de validation.
Découvrez des anticorps KLRK1 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de KLRK1 dans plusieurs espèces, y compris Human, Mouse, Rat, Cow, Monkey, Panda, Dog, Guinea Pig, Horse, Rabbit, et prend en charge diverses applications de recherche telles que FACS, WB, ELISA, IHC, IF (cc).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants KLRK1, issus de différents hôtes tels que Rabbit, Mouse, Human. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de KLRK1 sont KLRK1, Klrk1, NKG2D.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| KLRK1 anticorps (AA 90-232) | Souris | Lapin Polyclonal |
|
527,38 €
Voir le prix
|
|
| KLRK1 anticorps | Souris | Rat Monoclonal |
|
599,57 €
Voir le prix
|
|
| KLRK1 anticorps | Souris | Rat Monoclonal |
|
599,57 €
Voir le prix
|
|
| KLRK1 anticorps (AA 80-160) | Humain, Souris, Rat | Lapin Polyclonal |
|
546,69 €
Voir le prix
|
|
| KLRK1 anticorps (AA 167-216) | Humain, Souris, Rat | Lapin Polyclonal |
|
546,69 €
Voir le prix
|
|
| KLRK1 anticorps | Humain | Souris Monoclonal |
|
577,99 €
Voir le prix
|
|
| KLRK1 anticorps | Humain | Souris Monoclonal |
|
577,99 €
Voir le prix
|
|
| Recombinant KLRK1 anticorps (AA 64-462, AA 123-462) | Humain | Souris Monoclonal |
|
624,00 €
Voir le prix
|
|
| Recombinant KLRK1 anticorps | Souris | Rat Monoclonal |
|
624,00 €
Voir le prix
|
|
| Recombinant KLRK1 anticorps | Souris | Lapin Chimeric |
|
624,00 €
Voir le prix
|
|
| Recombinant KLRK1 anticorps (AA 64-462, AA 123-462) | Humain | Souris Monoclonal |
|
624,00 €
Voir le prix
|
|
| KLRK1 anticorps (AA 73-216) (Biotin) | Humain | Lapin Polyclonal |
|
328,90 €
Voir le prix
|
|
| KLRK1 anticorps (AA 73-216) (FITC) | Humain | Lapin Polyclonal |
|
328,90 €
Voir le prix
|
|
| KLRK1 anticorps (AA 73-216) (HRP) | Humain | Lapin Polyclonal |
|
328,90 €
Voir le prix
|
|
| Recombinant KLRK1 anticorps (Biotin) | Humain | Human, Lapin Chimeric |
|
1.098,46 €
Voir le prix
|
|
| KLRK1 anticorps (PE) | Souris | Rat Monoclonal |
|
1.135,00 €
Voir le prix
|
|
| KLRK1 anticorps (Biotin) | Souris | Hamster Monoclonal |
|
1.233,86 €
Voir le prix
|
|
| KLRK1 anticorps (APC) | Souris | Rat Monoclonal |
|
1.665,44 €
Voir le prix
|
|
| Recombinant KLRK1 anticorps (AA 64-462, AA 123-462) | Humain | Lapin Chimeric |
|
624,00 €
Voir le prix
|
|
| KLRK1 anticorps (AA 121-219) (AbBy Fluor® 680) | Rat | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 90-232
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- BR (Blocking Reagent: Application indiquée)
- Reactivité
- Souris
- Hôte
- Rat
- Clonalité
- Monoclonal
- Clone
- CX5
- Conjugué
- unconjugated
- Isotype
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- BR (Blocking Reagent: Application indiquée)
- Reactivité
- Souris
- Hôte
- Rat
- Clonalité
- Monoclonal
- Clone
- MI-6
- Conjugué
- unconjugated
- Isotype
- IgG2a, lambda
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 80-160
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 167-216
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IP (Immunoprecipitation: Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Func (Functional Studies: Application indiquée)
- BR (Blocking Reagent: Application indiquée)
- Neut (Neutralization: Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 1D11
- Conjugué
- unconjugated
- Isotype
- IgG1
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IP (Immunoprecipitation: Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Func (Functional Studies: Application indiquée)
- BR (Blocking Reagent: Application indiquée)
- Neut (Neutralization: Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 1D11
- Conjugué
- unconjugated
- Isotype
- IgG1
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- BP (Blocking Peptide: Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 11B2D10
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG1, kappa
- Epitope
- AA 123-462, AA 64-462
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Neut (Neutralization: Application indiquée)
- BP (Blocking Peptide: Application indiquée)
- Reactivité
- Souris
- Hôte
- Rat
- Clonalité
- Monoclonal
- Clone
- CX-5
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG1, lambda
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Neut (Neutralization: Application indiquée)
- BP (Blocking Peptide: Application indiquée)
- Reactivité
- Souris
- Hôte
- Lapin
- Clonalité
- Chimeric
- Clone
- CX-5
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG, lambda
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- BP (Blocking Peptide: Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 6E5A7
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG2b, kappa
- Epitope
- AA 123-462, AA 64-462
Primary Antibody
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Biotin
- Isotype
- IgG
- Epitope
- AA 73-216
Primary Antibody
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 73-216
Primary Antibody
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- HRP
- Isotype
- IgG
- Epitope
- AA 73-216
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Human, Lapin
- Clonalité
- Chimeric
- Clone
- DMC287
- Conjugué
- Biotin
- Fragment
- Fc fragment
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG1
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Souris
- Hôte
- Rat
- Clonalité
- Monoclonal
- Clone
- CX5
- Conjugué
- PE
- Isotype
- IgG1 kappa
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Souris
- Hôte
- Hamster
- Clonalité
- Monoclonal
- Clone
- A10
- Conjugué
- Biotin
- Isotype
- IgG
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Souris
- Hôte
- Rat
- Clonalité
- Monoclonal
- Clone
- CX5
- Conjugué
- APC
- Isotype
- IgG1 kappa
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- BP (Blocking Peptide: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Chimeric
- Clone
- 11B2D10
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG, kappa
- Epitope
- AA 123-462, AA 64-462
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 680
- Isotype
- IgG
- Epitope
- AA 121-219
Dernières publications pour nos KLRK1 Anticorps
: "Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis." dans: RNA biology, Vol. 16, Issue 11, pp. 1592-1603, (2019) (PubMed).
: "Quantitative and functional analysis of CD69(+) T regulatory lymphocytes in patients with periodontal disease." dans: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, (2016) (PubMed).
: "Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo." dans: PLoS pathogens, Vol. 12, Issue 8, pp. e1005788, (2016) (PubMed).
: "NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma." dans: Oncotarget, Vol. 7, Issue 42, pp. 68513-68526, (2016) (PubMed).
: "Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain." dans: BMC cancer, Vol. 15, pp. 1011, (2015) (PubMed).
: "Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human ..." dans: PLoS pathogens, Vol. 11, Issue 3, pp. e1004671, (2015) (PubMed).
: "Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1." dans: PLoS ONE, Vol. 10, Issue 5, pp. e0125544, (2015) (PubMed).
: "Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts." dans: Journal of experimental & clinical cancer research : CR, Vol. 34, pp. 98, (2015) (PubMed).
: "NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure." dans: PLoS ONE, Vol. 10, Issue 8, pp. e0134568, (2015) (PubMed).
: "Central nervous system acute lymphoblastic leukemia: role of natural killer cells." dans: Blood, Vol. 125, Issue 22, pp. 3420-31, (2015) (PubMed).
: "Quantitative and functional analysis of CD69(+) T regulatory lymphocytes in patients with periodontal disease." dans: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, (2016) (PubMed).
: "Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo." dans: PLoS pathogens, Vol. 12, Issue 8, pp. e1005788, (2016) (PubMed).
: "NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma." dans: Oncotarget, Vol. 7, Issue 42, pp. 68513-68526, (2016) (PubMed).
: "Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain." dans: BMC cancer, Vol. 15, pp. 1011, (2015) (PubMed).
: "Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human ..." dans: PLoS pathogens, Vol. 11, Issue 3, pp. e1004671, (2015) (PubMed).
: "Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1." dans: PLoS ONE, Vol. 10, Issue 5, pp. e0125544, (2015) (PubMed).
: "Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts." dans: Journal of experimental & clinical cancer research : CR, Vol. 34, pp. 98, (2015) (PubMed).
: "NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure." dans: PLoS ONE, Vol. 10, Issue 8, pp. e0134568, (2015) (PubMed).
: "Central nervous system acute lymphoblastic leukemia: role of natural killer cells." dans: Blood, Vol. 125, Issue 22, pp. 3420-31, (2015) (PubMed).
Pseudonymes pour KLRK1 Anticorps
killer cell lectin like receptor K1 (KLRK1) Anticorpskiller cell lectin-like receptor subfamily K, member 1 (KLRK1) Anticorps
killer cell lectin-like receptor subfamily K, member 1 (Klrk1) Anticorps
killer cell lectin like receptor K1 (Klrk1) Anticorps
NKG2D protein (NKG2D) Anticorps
CD314 Anticorps
D6H12S2489E Anticorps
D12S2489E Anticorps
KLR Anticorps
KLRK1 Anticorps
NKG2-D Anticorps
NKG2D Anticorps
Nkg2d Anticorps
Nkrp2 Anticorps
Avez-vous cherché autre chose?
- KLRG1 Anticorps
- KLRF2 Anticorps
- KLRF1 Anticorps
- KLRC4 Anticorps
- KLRC3 Anticorps
- KLRC2 Anticorps
- KLRC1 Anticorps
- Klra7 Anticorps
- Klra6 Anticorps
- Klra3 Anticorps
- Klra2 Anticorps
- KLRA1 Anticorps
- Klotho beta Anticorps
- Klotho Anticorps
- KLLN Anticorps
- KLKB1 Anticorps
- Klk1b27 Anticorps
- Klk1b22 Anticorps
- KLHL9 Anticorps
- KLHL7 Anticorps
- KMO Anticorps
- KNDC1 Anticorps
- KNG1 Anticorps
- KNSTRN Anticorps
- KNTC1 Anticorps
- KPNA1 Anticorps
- KPNA2 Anticorps
- KPNA3 Anticorps
- KPNA4 Anticorps
- KPNA5 Anticorps
- KPNA6 Anticorps
- KPNA7 Anticorps
- KPNB1 Anticorps
- KPTN Anticorps
- KRAB Box Domain Containing 4 Anticorps
- KREMEN1 Anticorps
- KREMEN2 Anticorps
- KRI1 Anticorps
- KRIT1 Anticorps
- KRR1 Anticorps
Vous êtes ici:
